BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 758244)

  • 1. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plasma protein binding on the anticoagulant action of warfarin in rats.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):405-8. PubMed ID: 1197921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of naproxen on protein binding of warfarin in human serum.
    Yacobi A; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):369-72. PubMed ID: 981793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects.
    Millar E; Coles S; Wyld P; Nimmo W
    Clin Pharmacokinet; 1992; 22 Suppl 1():102-6. PubMed ID: 1319866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
    Apseloff G; Wilner KD; Gerber N
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine does not affect the anticoagulant activity of warfarin.
    Krämer G; Tettenborn B; Klosterskov Jensen P; Menge GP; Stoll KD
    Epilepsia; 1992; 33(6):1145-8. PubMed ID: 1464277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age as a determinant of sensitivity to warfarin.
    Shepherd AM; Hewick DS; Moreland TA; Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):315-20. PubMed ID: 901699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of terodiline on anticoagulation effect of warfarin and steady-state plasma levels of warfarin enantiomers in healthy volunteers.
    Höglund P; Paulsen O; Bogentoft S
    Ther Drug Monit; 1989 Nov; 11(6):667-73. PubMed ID: 2595747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.
    Williams RL; Schary WL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Jul; 20(1):90-7. PubMed ID: 1277729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between diflunisal and warfarin.
    Serlin MJ; Mossman S; Sibeon RG; Tempero KF; Breckenridge AM
    Clin Pharmacol Ther; 1980 Oct; 28(4):493-8. PubMed ID: 7408409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of coumarin anticoagulants. XLVI: Effect of treatment of phenobarbital on pharmacokinetics of (S)-(-)-warfarin in rats.
    Yacobi A; Slattery JT; Levy G
    J Pharm Sci; 1980 Jun; 69(6):634-6. PubMed ID: 7205571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
    Slattery JT; Yacobi A; Levy G
    J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.